The products are being recalled because our testing has found these lots to be superpotent. The recalled tablets come in 100-count bottles, and they have an expiration date of July, August, November, or December of 2020. (Source: FDA) By Gray News Staff | September 21, 2020 at 11:47 AM EDT - Updated September 21 at 11:49 AM (Gray News) - The U.S. Food and Drug Administration issued a recall notice for Acella Pharmaceuticals, LLC for two lots of medicine for people with hypothyroidism. The product may have up to 115.0% of the labeled amount of Liothyronine (T3). Acella Pharmaceuticals thyroid medication under voluntary recall. NP Thyroid is a natural preparation derived from porcine thyroid glands. One lot of 15-mg and one lot of 120-mg NP Thyroid tablets, USP were voluntarily recalled by … See product images. Acella Pharmaceuticals has issued a recall with the U.S. Food and Drug Administration of three strengths of medication used to treat hypothyroidism (underactive thyroid.). Patients should talk to their healthcare professional before they stop taking their NP Thyroid medicine. Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency Provided by PR Newswire Sep 18, 2020 3:05 PM UTC (Gray News) - The U.S. Food and Drug Administration issued a recall notice for Acella Pharmaceuticals, LLC for two lots of medicine for people with hypothyroidism. Patients who are currently taking NP Thyroid from the lots being recalled should not discontinue use without contacting their healthcare provider for further guidance and/or a replacement prescription. These lots were distributed nationwide in the USA to Acella’s direct accounts. The products subject to recall … The product may have up to 115.0% of the labeled amount of Liothyronine (T3). Adverse reactions or quality problems experienced with its use may be reported to the FDA’s MedWatch Adverse Event Reporting program. More Recalls, Market The affected products were recalled due to the results from the samples that were tested by the U.S. Food and Drug Administration (FDA). This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. Patients should talk to their healthcare professional before they stop taking their NP Thyroid® medicine. September 17, 2020 -- Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid ®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because our testing has found these lots to be superpotent. (Gray News) - The U.S. Food and Drug Administration issued a recall notice for Acella Pharmaceuticals, LLC for two lots of medicine for people with hypothyroidism. In addition, Acella failed to pursue a long-term stability study for lots of NP Thyroid produced by its CMO and a new API supplier back in May 2019, the FDA said. ABOUT ACELLA and NP THYROID: Acella Pharmaceuticals, LLC is a specialty pharmaceutical company. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. is voluntarily recalling a total of 13 lots of 30mg, 60mg, and 90mg NP Thyroid® to the patient level. Consumers with questions can email Acella Pharmaceuticals at recall@acellapharma.com or contact 1-888-280-2044 Monday through Friday from 8 a.m. to 5 p.m. https://www.knoe.com/2020/09/21/thyroid-pills-recalled-by-acella-pharmaceuticals Risk Statement: Patients being treated for hypothyroidism (underactive thyroid), who receive superpotent NP Thyroid, may experience signs and symptoms of hyperthyroidism (overactive thyroid) which include, but are not limited to, weight loss, heat intolerance, fatigue, muscle weakness, hypertension, chest pain, rapid heart rate, or heart rhythm disturbances. Consumers with questions about the recall can email Acella Pharmaceuticals at recall@acellapharma.com or contact Acella Customer Service at 1-800-541-4802, Monday through Thursday from 9:00 am to 5:00 pm ET and Friday from 9:00 am to 12:30 pm ET. May 21, 2020 Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid ® (thyroid tablets, USP) to the consumer level. Download PDF Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. Our diverse portfolio of therapeutic products helps patients with a variety of healthcare needs. The FDA announced a recall of thyroid medicine from Acella Pharmaceuticals, LLC . The product may have up to 115.0% of the labeled amount of Liothyronine (T3). Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. Patients who are currently taking NP Thyroid® from the lots being recalled should not discontinue use without contacting their healthcare provider for further guidance and/or a replacement prescription. Consumers can also call Acella at 1-800-541-4802 or by email at recall@acellapharma.com. Do you have any questions or comments about our products, company or website? The voluntary recall of NP Thyroid by Acella Pharmaceuticals, LLC. In May 2020, Acella Pharmaceuticals recalled 13 lots of NP Thyroid tablets due to super-potency. The FDA recommends that patients currently taking NP Thyroid should not discontinue taking the medications without talking to their prescribing physician for guidance and a new prescription. NP had always received good reviews via patient comments in various groups, including the Stop the Thyroid Madness Facebook page. Find several options for contacting us! Acella Pharmaceuticals Recalls Thyroid Tablets Due to Sub Potency Fourth Estate Wire - Modified date: February 18, 2021 0 Acella Pharmaceuticals, LLC recalled one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP to the consumer level. Issues a Voluntary Nationwide Recall of Certain Lots of NP Thyroid®(Thyroid Tablets, USP) Due to Super Potency . Acella Pharmaceuticals – Recall of NP Thyroid ® (thyroid tablets) May 22, 2020 - Acella Pharmaceuticals announced a consumer-level recall of thirteen lots of NP Thyroid (thyroid tablets) because testing has found the recalled lots to be superpotent. NP Thyroid® (thyroid tablets, USP) is composed of levothyroxine and liothyronine, and used to treat hypothyroidism (underactive thyroid). The product may have up to 115.0% of the labeled amount of liothyronine (T3). To date, Acella has received two reports of adverse events known to be related to this recall. The product may have up to 115.0% of the labeled amount of liothyronine (T3). Patients have often happily … Acella Pharmaceuticals’ FDA-posted recall notice says testing determined 13 lots of its NP Thyroid tablets in 30 mg, 60 mg and 90 mg strengths were super potent. Written by Kathleen Doheny | Reviewed by Jessica Rodriguez CNP. Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The Food and Drug Administration website provides a list of the lots affected and can be found here. Acella is proactively notifying its wholesalers by email and phone to discontinue distribution of the product being recalled and is arranging for return of all recalled products. Acella Pharmaceuticals recalled one lot of 15 mg and one lot of 120 mg NP Thyroid brand tablets. Acella Pharmaceuticals’ NP Thyroid drug is distributed throughout the United States and comes in 30 mg, 60 mg, and 90 mg tablets. The products subject to recall are packed in 100-count bottles. Visit GoodRx to find the lowest product pricing in your area. Acella Pharmaceuticals, LLC. The product may have up to 115.0% of the labeled amount of Liothyronine (T3).” “The products are being recalled because these lots have been found to be super potent by the manufacture. The products are being recalled because these lots have been found to be super potent by the manufacturer. These lots were distributed nationwide in the USA to Acella’s direct accounts. Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency Published: Sep 18, 2020 ATLANTA , Sept. 18, 2020 /PRNewswire/ -- Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid ® , Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. Acella Pharmaceuticals is reporting the recall to its wholesale distributors in order to stop distributing the medications. To best identify the product, the NDC’s, Product Description, Lot Numbers and Expiration Dates are listed. Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The products are being recalled because our testing has found these lots to be superpotent. Acella Pharmaceuticals is recalling one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets [levothyroxine (T4) and liothyronine (T3)]. Safety Alerts, An official website of the United States government, : The product may have up to 115.0% of the labeled amount of Liothyronine (T3). Risk Statement: Patients being treated for hypothyroidism (underactive thyroid), who receive superpotent NP Thyroid®, may experience signs and symptoms of hyperthyroidism (overactive thyroid) which include, but are not limited to, weight loss, heat intolerance, fatigue, muscle weakness, hypertension, chest pain, rapid heart rate, or heart rhythm disturbances. You can also visit www.npthyroid.com for more information and answers to frequently asked questions. To date, Acella has received two reports of adverse events known to be related to this recall. The products are being recalled because our testing has found these lots to be superpotent. 1111 E Herndon Ave #204, Fresno, CA 93720 © 2021 JKA Attorneys Website Maintained by BCT Consulting The voluntary recall of NP Thyroid by Acella Pharmaceuticals, LLC. •Postherpetic Neuralgia ( 2.1) •Dose can be titrated up as needed to a dose of 1800 mg/day •Day 1: Single 300 mg dose •Day 2: 600 mg/day (i.e., 300 mg two times a day) •Day 3: 900 mg/day (i.e., 300 mg three times a day) () •Epilepsy with Partial Onset Seizures ( 2.2) •Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg … Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Sub Potency Sep 17, 2020 | Audience: Consumer, Health Professional, Pharmacy. NEW YORK (CBSNewYork) – Acella Pharmaceuticals is voluntarily recalling its NP Thyroid tablets after testing found them to be “superpotent.” The company says the affected products may contain up to 115% of the labeled amount of Liothyronine. Acella Pharmaceuticals, LLC is a specialty pharmaceutical company committed to innovating the healthcare field by bringing quality and affordable products to our customers and patients. The … Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. See product images. Acella is proactively notifying its wholesalers by email and phone to discontinue distribution of the product being recalled and is arranging for return of all recalled products. NP Thyroid (thyroid tablets, USP) is composed of levothyroxine and liothyronine, and used to treat hypothyroidism (underactive thyroid). One lot of 15-mg and … Some lots of these NP Thyroid tablets have been recalled by Acella Pharmaceuticals. Feb 16, 2021 (AmericaNewsHour) -- Recently, a significant growth in healthcare spending have been observed in the low- and middle-income nations. Acella Pharmaceuticals, LLC. Withdrawals, & The products are being recalled because our testing has found these lots to be superpotent. This past week, Acella Pharmaceuticals voluntarily recalled a total of 13 lots of 30-mg, 60-mg, and 90-mg NP thyroid tablets, citing issues that the medication is ''super potent." The products subject to recall are packed in 100-count bottles. FDA does not endorse either the product or the company. Before sharing sensitive information, make sure you're on a federal government site. Alpharetta-based Acella Pharmaceuticals is voluntarily recalling 13 lots of a thyroid medication after receiving two reports that patients who … The site is secure. Recalls, Market Withdrawals, & Safety Alerts, Recalls, Market Withdrawals and Safety Alerts, Recalls, Market Withdrawals, & Safety Alerts, Archive for Recalls, Market Withdrawals & Safety Alerts, Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency, Recent Recalled Product Photos on FDA's Flickr Photostream. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. For legal information regarding our products, please view our Product Disclaimer. Download PDF Acella Pharmaceuticals is recalling one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets [levothyroxine (T4) and liothyronine (T3)]. One lot of 15-mg and … This is a quote directly from the letter. Its desiccated thyroid called NP Thyroid came out around 2010. Pregnant women who take superpotent NP Thyroid® may also experience negative maternal and fetal outcomes including miscarriage and/or impairment to fetal development. A recall notice on the FDA’s website from Acella Pharmaceuticals states that one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets, USP were found to be “sub potent.” Pregnant women who take superpotent NP Thyroid may also experience negative maternal and fetal outcomes including miscarriage and/or impairment to fetal development. The FDA announced a recall of thyroid medicine from Acella Pharmaceuticals, LLC . Consumers with questions about the recall can email Acella Pharmaceuticals at recall@acellapharma.com or contact Acella Customer Service at 1-800-541-4802, Monday through Thursday from 9:00 am to 5:00 pm ET and Friday from 9:00 am to 12:30 pm ET. Photo credits: Acella pharmaceuticals. With Elena Christofides MD. On Jun 8, 2020 I received a letter from my pharmacy about a voluntary recall by Acella Pharmaceuticals, LLC on 13 lots of NP Thyroid 30, 60, and 90mg. Its desiccated thyroid called NP Thyroid came out around 2010. https://www.kold.com/2020/09/21/thyroid-pills-recalled-by-acella-pharmaceuticals (Source: FDA) By Gray News Staff | September 21, 2020 at 10:47 AM CDT - Updated September 21 at 10:49 AM (Gray News) - The U.S. Food and Drug Administration issued a recall notice for Acella Pharmaceuticals, LLC for two lots of medicine for people with hypothyroidism. Acella had received four reports of adverse events for these lot numbers possibly related to this recall. Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The Acella Pharmaceuticals recall is the most recent, but it's far from the only one. Acella Pharmaceuticals: NP Thyroid Medication Recall Acella voluntarily recalls thyroid supplement, saying it may have up to 115% of the labeled amount of liothyronine . ET. May 22, 2020: “Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. One lot of 15-mg and one lot of 120-mg NP Thyroid tablets, USP [levothyroxine (T4) and liothyronine (T3)] were voluntarily recalled by the company. The products are being recalled because our testing has found these lots to be superpotent. PRIVACY POLICY | TERMS & CONDITIONS    ©2020 ACELLA PHARMACEUTICALS, LLC. Adverse events or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax. “Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. So far, Acella says it has received four reports of "adverse events" for these lot numbers, possibly related to the recall. Acella Pharmaceuticals, LLC recalled one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. Acella Pharmaceuticals – Recall of NP Thyroid ® (thyroid tablets) May 22, 2020 - Acella Pharmaceuticals announced a consumer-level recall of thirteen lots of NP Thyroid (thyroid tablets) because testing has found the recalled lots to be superpotent. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. To best identify the product, the NDC’s, Product Description, Lot Numbers and Expiration Dates are listed. Earlier this month, another manufacturer called RLC Labs recalled 483 lots of two thyroid medications called WP Thyroid and Nature-Thyroid for sub-potency. The .gov means it’s official.Federal government websites often end in .gov or .mil. The product may have up to 115.0% of the labeled amount of Liothyronine (T3) (FDA). ABOUT ACELLA and NP THYROID: Acella Pharmaceuticals, LLC is a specialty pharmaceutical company. Acella Pharmaceuticals’ FDA-posted recall notice says testing determined 13 lots of its NP Thyroid tablets in 30 mg, 60 mg and 90 mg strengths were super potent. The products are being recalled because testing has found these lots to be sub potent.

Chad Discord Emoji, Hornady Titanium Nitride Dies, Professional Spray Guns For Sale, Vigor Game Clothing, Cons Of Private Prisons,